comparemela.com

Latest Breaking News On - ஹ்யூகோ ஆரோக்கியம் - Page 1 : comparemela.com

ARBs Prove Safer Than ACEs as First-Line BP Therapy

ARBs Prove Safer Than ACEs as First-Line BP Therapy
physiciansweekly.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from physiciansweekly.com Daily Mail and Mail on Sunday newspapers.

You can help find better treatments for COVID-19 through a high-tech app

You can help find better treatments for COVID-19 through a high-tech app UTHealth using app to track long-term COVID-19 effects for new study The University of Texas Health Science Center is one of eight sites in the country joining the new study to see how the coronavirus is affecting Houstonians. HOUSTON - Researchers at UTHealth are asking for your help to find better treatments for COVID-19. They re teaming up with the Centers for Disease Control and using a high-tech app to track long-term effects of the virus. One thing we ve all learned about COVID-19 is it affects everyone differently. The CDC is gathering every piece of information it can to try to get a better understanding of it.

New COVID-19 Study Will Examine Long-term Impact on Survivors

December 18, 2020 COVID-19 has wreaked havoc around the globe, with more than 310,000 fatalities occurring in the United States alone. While much has been learned about the virus since it was first detected, the long-term effects on the health of coronavirus survivors may take years to understand. To find some answers, investigators from the Yale School of Medicine and partners across the country are launching a nationwide study of patients who were infected. INSPIRE (Innovative Support for Patients with SARS COV-2 Infections Registry) is a Centers for Disease Control and Prevention-funded project led by Yale University with Rush University Medical Center; the University of Washington; the University of Texas Health Science Center at Houston; the University of Texas Southwestern Medical Center; the University of California, Los Angeles; the University of California, San Francisco; and Thomas Jefferson University. They will track 4,800 individuals to assess the longitudinal outcomes

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.